Intra-Abdominal Desmoid Tumour (DT) with Pelvic Extension-A Case Report
Published: January 1, 2014 | DOI: https://doi.org/10.7860/JCDR/2014/.3901
Sathish Selva Kumar, Padmini Ramachandran, Veena. G, Napa Madhusudhan, Uday Kumbhar
1. Assistant Professor, Department of Pathology, ESI Medical College and Post Graduate Institute of Medical Science and Research (PGIMSR).
2. Senior Resident, Department of Pathology, ESI Medical College and Post Graduate Institute of Medical Science and Research (PGIMSR).
3. Senior Resident, Department of Pathology, ESI Medical College and Post Graduate Institute of Medical Science and Research (PGIMSR).
4. Assistant Professor, Department of Surgery, ESI Medical College and Post Graduate Institute of Medical Science and Research (PGIMSR).
5. Associate Professor, Department of Surgery, ESI Medical College and Post Graduate Institute of Medical Science and Research (PGIMSR),
K.K. Nagar, Chennai-600078, Tamil Nadu, India.
Correspondence
Dr. Sathish Selva Kumar,
F-4, Shiv Apartments, No.1, 3rd Cross Street, Kalaimagalnagar, Ekkattuthangal, Chennai-600032, TamilNadu, India.
Phone: 09884858501, E-mail: sathishpath17@gmail.com
Desmoid Tumour (DT) is a rare benign, myofibroblastic tumour originating from muscle fascia with tendency to recur but, it rarely metastasizes. We are reporting here a case of DT that presented as an intra-abdominal mass with pelvic extension in a patient who underwent hysterectomy for fibroid uterus seventeen years ago. A clinical diagnosis of ovarian malignancy was made. Ovarian tumour markers for surface epithelial and germ cell tumours were negative. Imaging studies suggested DT and the same was excised surgically. A histopathological diagnosis of DT was made and confirmed with immunohistochemistry (IHC) markers. DT should always be considered especially in female patients with previous history of surgery. A complete surgical excision is the treatment of choice with recurrent cases requiring radiotherapy. A differential diagnosis like sarcoma and further toxic chemotherapy can be avoided with careful histopathological evaluation and IHC confirmation of DTs.
[
FULL TEXT ] | [ PDF]